Abstract
Objective
To observe the clinical efficacy of Quyu Jiedu Recipe (祛瘀解毒方, QJR) in treating endometriosis (EM), and to explore the levels of vascular endothelial growth factor (VEGF) and cell proliferative nucleoprotein antigen (Ki-67), their changes before and after treatment and the clinical significance in the trial.
Methods
Fifty patients of EM were randomly assigned to two groups. The 26 patients in the QJR group were treated with QJR, and the 24 patients in the gestrinone (GT) group with gestrinone. Besides, a normal control group with 20 healthy women was set up. The therapeutic effects in the two treated groups were compared. Expressions of VEGF and Ki-67 in eutopic endometrium of all subjects (with both patients and healthy women at the median secretive phase) were determined with immunohistochemical stain before treatment, and the determination in the two treated groups was repeated after 3-month treatment in the same phase.
Results
Before treatment, the VEGF and Ki-67 expression positive rates and their mean optic density (MOD) were higher in patients than in healthy women (P<0.05). After treatment, the positive rate and MOD of VEGF expression lowered significantly than before treatment (P<0.05), but those of Ki-67 changed insignificantly, and comparison between the two treated groups showed no significant difference (P>0.05).
Conclusion
QJR could markedly improve the symptoms of menorrhagia and menstrual disorder, and its mechanism might be related with the lowering of eutopic endometrial VEGF expression. VEGF and Ki-67 show a high expression in eutopic endometrium of patients with EM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lang JH. Study and opinion on endometriosis. Chin J Obstet Gynecol 2003; 38(8): 478–480.
Formulated and issued by Ministry of Health, People’s Republic of China. Guiding principle of clinical research on new drugs of TCM. 1st ed. 1993: 267–271.
Folkman J, Shing Y. Angiogenesis. Biol Chem 1992; 267: 10931–10934.
Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2002; 9(5): 285–296.
Tan XJ, Lang JH, Liu DY, et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA on patients with endometriosis. Fertil Steril 2002; 78(1): 148–153.
Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell production. Cancer 1983; 31: 13–20.
Getdes J, Lemke H, Baisch H, et al. Cell cycle analysis of cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. Immunol 1984; 133: 1701–1715.
Baldwin AS. The NF-KB, IKB proteins new discoveries and insights. Annu Rev Immunol 1996; 14: 649–683.
May MJ, Ghosh S. IkappaB kinases: kinsmen with different crafts. Science 1999; 284: 271–273.
Olive DL, Pritts EA. Treatment of endometriosis. N Eng J Med 2001; 345: 266–275.
Lian F, Wang XB, Zhang JW, et al. Thinking and methods of TCM treatment of endometriosis. J Tradit Chin Med 2002; 43(7): 545–546.
Ji ZQ, Gao XX, Song LQ, et al. Experimental study on antiplatelet aggregation in human by 63 kinds of lipid regulating drugs of Chinese Materia Medica. Shandong J Tradit Chin Med 1998; 17: 365–367.
Ye ZY, Ren SG, Li FQ, et al. Effects of paeonol on the microcirculation of rats. Chin J Hemorheol 1999; 9(3): 137–138.
Dictionary of Chinese Materia Medica. Shanghai: Shanghai Scientific and Technical Press, 1986: 478–482, 1093–1097, 1127–1130.
Liu XJ, Chen WN, Dai G. Study on analgesic action and intolerance of paeonol. Chin Pharmacol Bull 1993; 9(6): 464–467.
Kang BY, Chung SW, Kim SH, et al. Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from salvia miltiorrhiza. Immunopharmacology 2000; 49: 355–361.
Li FC, Zhou XL, Mo HL, et al. Experimental study on immunity enhancing effect of Paeonol Injection. Chin J Integr Tradit West Med 1994; 14(1): 37–38.
Luo ZH. Effect of several kinds of drugs in Chinese material medica on neutrophils in mice. Med J Chin People’s Liberat Army 1994; 19(4): 271.
Zhang YW, Yu Q, Liu P. Minutes of the Fourth National Conference on Obstetrics, Gynecology and Endocrinology. Chin J Obstet Gynecol 2002; 37(5): 263–266.
Shifren JL, Tseng JF, Zaloudek CJ, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81(8): 3112–3118.
Moller B, Rasmussen C, Lindblom B, et al. Expression of the angiogenic growth factor VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 2001; 7(1): 65–72.
Lian F, Liu HP, Wang YX, et al. Study on mechanism of Quyujiedu method in treating endometriosis of stasis-toxic syndrome type. Chin J Integr Tradit West Med 2006; 26(2): 110–113.
Levitas E, Chamoun D, Udoff LC, et al. Periovulatory and interleukin-1 beta-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: potential role for VEGF in the promotion of preovulatory angiogenesis and vascular permeability. J Soc Cynecol Investig 2000; 7: 51–60.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by Research Projects of Medical Science and Hygiene of Shandong Province 1999 (No. 42)
Rights and permissions
About this article
Cite this article
Lian, F., Liu, Hp., Wang, Yx. et al. Expressions of VEGF and Ki-67 in eutopic endometrium of patients with endometriosis and effect of Quyu Jiedu Recipe (祛瘀解毒方) on VEGF expression. Chin. J Integ. Med. 13, 109–114 (2007). https://doi.org/10.1007/s11655-007-0109-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11655-007-0109-6